Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 224,254 | 128,101 | 55,872 | 346,071 | 41,699 |
| Marketable Securities | 147,895 | 104,312 | 207,914 | N/A | N/A |
| Receivables | 173 | 505 | 7,656 | N/A | N/A |
| TOTAL | $377,440 | $236,212 | $275,886 | $348,666 | $43,591 |
| Non-Current Assets | |||||
| PPE Net | 29,483 | 33,803 | 27,075 | 12,325 | 4,623 |
| Other Non-Current Assets | 31,809 | 33,740 | 39,428 | 5,338 | 1,164 |
| TOTAL | $61,292 | $67,543 | $66,503 | $17,663 | $5,787 |
| Total Assets | $438,732 | $303,755 | $342,389 | $366,329 | $49,378 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,215 | 11,152 | 7,862 | 6,558 | 7,066 |
| Accrued Expenses | 18,785 | 14,600 | 14,580 | 10,080 | 2,529 |
| Other current liabilities | N/A | N/A | N/A | N/A | 19,680 |
| TOTAL | $156,946 | $46,592 | $25,569 | $16,638 | $29,275 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 117,232 | 17,678 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 39,001 | 42,877 | 43,874 | 0 | 67,764 |
| TOTAL | $58,850 | $77,913 | $45,407 | $2,176 | $68,831 |
| Total Liabilities | $215,796 | $124,505 | $70,976 | $18,814 | $98,106 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,510 | 50,154 | 49,359 | 46,630 | N/A |
| Common Shares | 6 | 5 | 5 | 5 | 1 |
| Retained earnings | -438,588 | -365,888 | -230,536 | -122,035 | -48,077 |
| Other shareholders' equity | -3,356 | -2,724 | -1,752 | -2,021 | -1,056 |
| TOTAL | $222,936 | $179,250 | $271,413 | $347,515 | $-48,728 |
| Total Liabilities And Equity | $438,732 | $303,755 | $342,389 | $366,329 | $49,378 |